Topic: HYPERA
7 results were found.
Uruguay decreed universal and free care for hyperacute stroke treatment - August 16, 2022
CADE conditionally clears acquisition of portfolio of medicines of Takeda by Hypera - January 25, 2021
Alzheimer's sign: Abnormal brain hyperactivation - January 22, 2021
Cade approves the acquisition of products from the brand Buscopan by Hypera, with restrictions - July 31, 2020
Eurofarma acquires Hypera Pharma assets in Latin America - March 20, 2020
Takeda to divest select assets in Latin America to Hypera Pharma for $825 million - March 2, 2020
Attention deficit hyperactivity disorder - November 24, 2010